Body composition and mortality in chronic obstructive pulmonary disease
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index; 1 of the 47 sources its claims cite were checked for support.
Overview
CoChat Summary
TL;DR
In 412 patients with moderate-to-severe COPD, fat-free mass index independently predicted all-cause mortality, whereas fat mass index did not. Low fat-free mass categories (cachexia and muscle atrophy) had worse survival than no impairment, supporting body-composition assessment as a systemic marker in COPD staging.
Key findings
- During a maximum follow-up of 5 y (mean 48 ± 20 mo), 46% of patients (n = 189) died.
- After adjustment for age, sex, FEV₁, IVC, PaCO₂, and PaO₂, fat-free mass index was an independent predictor of mortality (RR: 0.90; 95% CI: 0.84, 0.96; P = 0.003), but fat mass index was not (RR: 1.02; 95% CI: 0.95, 1.09; P = 0.680).
- Median survival was significantly worse in cachexia (26 mo; 95% CI: 21, 31 mo) and muscle atrophy (24 mo; 95% CI: 15, 33 mo) than in semistarvation (36 mo; 95% CI: 28, 44 mo) or no impairment (47 mo; 95% CI: 37, 57 mo) (P < 0.001).
- Cachexia was significantly more prevalent in GOLD stage IV than in GOLD stages II and III (P = 0.001); by SMI criteria, 51% of the total population was at moderate and 31% at high risk of physical disability.
Methods
- Cohort study of 412 clinically stable COPD patients (GOLD stages II–IV; FEV₁ 36 ± 14% of predicted, range 19–70%) screened for admission to a clinical pulmonary rehabilitation program between 1 January 1988 and 30 December 1991; mortality was assessed on 31 January 1993, with follow-up of 2–5 y or until death.
- Body composition was assessed by single-frequency bioelectrical impedance (50 Hz); fat-free mass was calculated with disease-specific equations, fat mass as body weight minus fat-free mass, and FFMI, FMI, and SMI were calculated and compared with reference values. Patients were stratified into cachexia, semistarvation, muscle atrophy, or no impairment by BMI and FFMI cutoffs.
- Main analysis used Kaplan-Meier survival curves, log-rank tests, and Cox proportional hazards models, unadjusted and adjusted for age, sex, disease severity (FEV₁, IVC, PaO₂, PaCO₂), and GOLD classification; P < 0.05 was considered significant.
Limitations
- Stated in the paper: the study population was skewed toward more males and more severe GOLD stages III and IV, and the semistarvation and muscle atrophy categories were relatively small.
- Stated in the paper: smoking status was not objectively verified (e.g., by cotinine measurements), and because smoking was not associated with mortality in these subjects, the reported models excluded smoking.
- Evident from the text: body composition was measured only at baseline, so the sequence of body-composition changes could not be established; emphysema severity was not adjusted for despite being discussed as potentially relevant; and the cohort was selected from rehabilitation screening in the southern Netherlands, which may limit generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 27 Not checked · 36 Own results and interpretations
None of the sources cited for this claim have been checked yet.
In the paper
“These studies all indicate that BIA may be a useful clinical screening instrument for characterization of the tissue-depletion pattern in chronic lung disease.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > DISCUSSION
What the sources say
- Not checked yetcites [12] Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol 2000;89:465-71. source
Checked before — its earlier verdict is held back until a new check runs.
- Not checked yetcites [19] Janssen I, Baumgartner RN, Ross R, Rosenberg IH, Roubenoff R. Skel- etal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 2004;159:413-21. source
Checked before — its earlier verdict is held back until a new check runs.
- Could not verifycites [20] Gosker HR, Engelen MP, van Mameren H, et al. Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr 2002;76:113-9. sourceExperimental — accuracy not yet measured
Our copy of Gosker et al. (2002) only uses BIA as one of two ways to determine fat-free mass (Methods, 'Assessment of body composition': single-frequency 50 kHz BIA with the disease-specific equation of Schols et al, ref 13) and reports that FFM_BIA correlated with total mean fiber cross-sectional area in the COPD patients (Results/'3-5' passage and Figure 3, r = 0.87, P < 0.001). No passage in our copy evaluates or states that BIA is a useful clinical screening instrument, nor does it use the notion of a 'tissue-depletion pattern' or generalize beyond its 15 stable COPD patients versus 15 controls (Study population). Searched: 'bioelectrical impedance analysis useful clinical screening instrument tissue depletion chronic lung disease', 'FFM BIA validity comparison DXA', 'screening instrument tissue depletion pattern chronic lung disease', 'discussion BIA fat-free mass muscle mass loss wasting clinical implications' — none returned a statement on BIA's screening utility. The validating comparison of BIA with deuterium dilution is credited elsewhere in the reference list (Schols et al. 1991, ref 13), but our copy does not attribute the screening-instrument conclusion to it, so this is not misattribution on our evidence. (LLM, conf=0.62)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Not checked yet
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Cachexia was significantly (P ҃ 0.001) more prevalent in GOLD stage IV than in GOLD stages II and III.”
- Also stated in: § Abstract · plain
“Semistarvation and muscle atrophy were equally distributed among disease stages, but the highest prevalence of cachexia was seen in GOLD stage IV.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
plainstates an associationn = 412- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
None of the sources cited for this claim have been checked yet.
In the paper
“In line with that study, male patients in the current study were at higher risk of physical disability than were female patients.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > RESULTS
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Univariate analysis showed that low BMI, FFMI, and FMI were significantly associated with increased mortality risk (Table 3).”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Forty-six percent of the patients (n ҃ 189) died during a maximum follow-up of 5 y.”
- Also stated in: § 6 x Ȁ SD (all such values). · plain
“The mean duration of follow-up was 48 Ȁ 20 mo, during which time 46% of the patients died.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > Abstract
plainn = 189- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 6 x Ȁ SD (all such values). · plain
32 more claims
Create a free account to see all 63 claims and to verify the 42 references still open.
- It may state two separate claims as one. 16
- Probably not a substantial claim. 13
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
“1.23”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
“1.68, 2.24; NS”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > RESULTS
“Mean FFMI in categories 2 and 4 was within median range (50th percentile) except for male patients in category 2, whose values were below the 10th percentile.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > DISCUSSION
“4: No impairment (n ҃ 55) | 59 | 17.6 Ȁ 2.2 | 90th”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > DISCUSSION
“physical disability risk was clearly lower in categories 3 and 4”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > RESULTS
“significantly (P 0.001) more patients were at moderate to high risk of disability in the cachexia and muscle atrophy categories (ie, 1 and 3) than in semistarvation and noimpairment categories (ie, 2 and 4)”
Citations
Cites
Celli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015 · cited 1×
“On the basis of numerous reports showing an association between BMI and mortality risk in COPD, Celli at al (26) recently proposed that clinical staging for COPD should be based not only on spirometry and resting arterial blood gases, eg, the recent GOLD criteria, but also on BMI, exercise capacity, and dyspnea score.”
BackgroundAssessment of fat-free mass using bioelectrical impedance measurements of the human body
Lukaski, H., Johnson, P., Bolonchuk, W., & Lykken, G. (1985) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/41.4.810 · Cited by 1,896 · cited 1×
“Bioelectrical impedance analysis (BIA) is an easy, safe, noninvasive, and convenient method of measuring the lean and fat body compartments (11).”
MethodEstimation of skeletal muscle mass by bioelectrical impedance analysis
Janssen, I., Heymsfield, S. B., Baumgartner, R. N., & Ross, R. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.89.2.465 · Cited by 1,482
Skeletal Muscle Cutpoints Associated with Elevated Physical Disability Risk in Older Men and Women
Janssen, I. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh058 · Cited by 1,190
Weight Loss Is a Reversible Factor in the Prognosis of Chronic Obstructive Pulmonary Disease
SCHOLS, A. M. W. J., SLANGEN, J., VOLOVICS, L., & WOUTERS, E. F. M. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.6.9705017 · Cited by 1,085
Self-citationPrognostic Value of Nutritional Status in Chronic Obstructive Pulmonary Disease
LANDBO, C., PRESCOTT, E., LANGE, P., VESTBO, J., & ALMDAL, T. P. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.6.9902115 · Cited by 1,033
Marquis, K., Debigaré, R., Lacasse, Y., LeBlanc, P., Jobin, J., Carrier, G., & Maltais, F. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2107031 · Cited by 844
Schols, A. M. W. J., Soeters, P. B., Dingemans, A. M. C., Mostert, R., Frantzen, P. J., & Wouters, E. F. M. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.5.1151 · Cited by 725
Self-citationFat-free mass index and fat mass index percentiles in Caucasians aged 18–98 y
Schutz, Y., Kyle, U., & Pichard, C. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802037 · Cited by 670
Schols, A. M., Soeters, P. B., Mostert, R., Pluymers, R. J., & Wouters, E. F. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.4.7551381 · Cited by 463
Self-citation
Cited by
Items 301–400 of 898
Pathobiology of frailty in lung disease
Koons, B., Greenland, J. R., Diamond, J. M., & Singer, J. P. (2020) · Translational research · doi:10.1016/j.trsl.2020.04.001 · Cited by 36
Management of patients with COPD during the COVID-19 pandemic
Attaway, A. H., & Hatipoglu, U. S. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.87a.ccc007 · Cited by 36
Lan, C., Yang, M., Lee, C., HUANG, Y., HUANG, C., HUANG, K., & Wu, Y. (2010) · Respirology · doi:10.1111/j.1440-1843.2010.01895.x · Cited by 36
Ramírez-Fuentes, C., Mínguez-Blasco, P., Ostiz, F., Sánchez‐Rodríguez, D., Messaggi-Sartor, M., Macías, R., Muniesa, J. M., Rodriguez, D. A., Vila, J., Perkisas, S., et al. (2018) · European Geriatric Medicine · doi:10.1007/s41999-018-0130-7 · Cited by 36
Accelerated Loss of Antigravity Muscles Is Associated with Mortality in Patients with COPD
Tanimura, K., Satô, S., Sato, A., Tanabe, N., Hasegawa, K., Uemasu, K., Hamakawa, Y., Oguma, T., Muro, S., & Hirai, T. (2020) · Respiration · doi:10.1159/000506520 · Cited by 36
van Wetering, C. R., van Nooten, F. E., Mol, S. J. M., Hoogendoorn, M., Mölken, M. P. M. H. R.-V., & Schols, A. M. W. J. (2008) · International Journal of COPD · doi:10.2147/copd.s2588 · Cited by 36
Self-citationHanson, C., Bowser, E. K., Frankenfield, D. C., & Piemonte, T. A. (2020) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2019.12.001 · Cited by 35
Sarcopenia in Solid Organ Transplantation
Carey, E. J. (2014) · Nutrition in Clinical Practice · doi:10.1177/0884533613520619 · Cited by 31
Lee, D.-W., & Choi, E.-Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164303 · Cited by 35
O’Brien, E., Zou, R. H., Hyre, N., Leader, J. K., Fuhrman, C. R., Sciurba, F. C., Nouraie, M. S., & Bon, J. M. (2021) · Thorax · doi:10.1136/thoraxjnl-2021-217710 · Cited by 34
Causas de muerte y predicción de mortalidad en la EPOC
Solanes, I., & Casán, P. (2010) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2010.04.001 · Cited by 34
Actualización en los mecanismos de disfunción muscular en la EPOC
Gea, J., & Barreiro, E. (2008) · Archivos de Bronconeumología · doi:10.1016/s0300-2896(08)70441-1 · Cited by 35
Ingadottir, A. R., Beck, A. M., Baldwin, C., Weekes, C. E., Geirsdottir, O. G., Ramel, A., Gislason, T., & Gunnarsdottir, I. (2019) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2018-000349 · Cited by 33
“In order to investigate the potential role of energy and protein-dense food for patients with COPD, the aims of this 12-month randomised intervention trial were to study the (1) feasibility of the recruitment, retention and provision of each intervention, and (2) the potential impact of the provision of snacks and ONS…”
MethodInfluentialPhase angle in assessment and monitoring treatment of individuals with respiratory disease
Benedetto, F. D., Marinari, S., & Blasio, F. D. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09786-5 · Cited by 33
Co-morbid manifestations in COPD
Wouters, E. F. �., Celis, M., Breyer, M., Rutten, E. P. A., Graat‐Verboom, L., & Spruit, M. A. (2007) · Respiratory Medicine COPD Update · doi:10.1016/j.rmedu.2007.08.003 · Cited by 35
Self-citationWhat community measurements can be used to predict bone disease in patients with COPD?
Bolton, C. E., Cannings-John, R. L., Edwards, P. H., Ionescu, A.-S., Evans, W. D., Pettit, R. J., Faulkner, T., Stone, M. D., & Shale, D. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2007.12.027 · Cited by 33
METABOLIC SYNDROME: CHALLENGING AND UNRESOLVED ISSUES
Чумакова, Г. А., Veselovskaya, N. G., Gritsenko, O. V., & Ott, A. (2014) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2014-3-63-71 · Cited by 34
Dual‐energy X‐ray absorptiometry is the method of choice to assess body composition in COPD
Miller, A., Strauss, B. J., Mol, S. J. M., Kyoong, A., Holmes, P. W., Finlay, P. N., Bardin, P. G., & Guy, P. (2009) · Respirology · doi:10.1111/j.1440-1843.2009.01499.x · Cited by 33
Crisafulli, E., Guerrero, M., Ielpo, A., Ceccato, A., Huerta, A. H., Gabarrús, A., Soler, N., Chetta, A. A., & Torres, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-27680-y · Cited by 32
Passos, L. B. D. S., Macedo, T. A. A., & De-Souza, D. A. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.10.015 · Cited by 32
Bernardes, S., Eckert, I. D. C., Burgel, C. F., Teixeira, P. J. Z., & Silva, F. M. (2022) · British Journal Of Nutrition · doi:10.1017/s0007114522000976 · Cited by 32
Balnis, J., Korponay, T. C., & Jaitovich, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030955 · Cited by 32
Chronic obstructive pulmonary disease phenotypes and balance impairment
Oancea, C. I., Voica, A., Tudorache, E., Crișan, A. F., Firă-Mladinescu, O., Tudorache, V., & Timar, B. (2016) · International Journal of COPD · doi:10.2147/copd.s101128 · Cited by 31
Frequency and functional translation of low muscle mass in overweight and obese patients with COPD
Machado, F. V. C., Spruit, M. A., Groenen, M. T. J., Houben‐Wilke, S., van Melick, P. P., Hernandes, N. A., Schols, A. M. W. J., Pitta, F. D. O., Wouters, E. F. �., & Franssen, F. M. E. (2021) · Respiratory Research · doi:10.1186/s12931-021-01689-w · Cited by 31
Self-citationKing, S., Nyulasi, I. B., Bailey, M., Kotsimbos, T. C., & Wilson, J. W. (2013) · Clinical Nutrition · doi:10.1016/j.clnu.2013.04.012 · Cited by 31
Vu, H. M., Nguyen, L. H., Tran, T. H., Pham, K. T. H., Phan, H. T., Nguyen, H. N., Tran, B. X., Latkin, C. A., Ho, C. S. H., & Ho, R. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16193623 · Cited by 31
Body composition profiling in a Dutch sarcoidosis population.
Cremers, J. P., Drent, M., Elfferich, M., Nelemans, P. J., Wijnen, P. A. H. M., Witteman, B. J. M., & Schols, A. M. W. J. (2013) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 31
Self-citationBody composition markers in older persons with COPD
Abbatecola, A. M., Fumagalli, A., Spazzafumo, L., Betti, V., Misuraca, C., Corsonello, A., Cherubini, A., Guffanti, E. E., & Lattanzio, F. (2013) · Age and Ageing · doi:10.1093/ageing/aft196 · Cited by 31
Arvidsson, D., Slinde, F., Nordenson, A., Larsson, S., & Hulthén, L. (2005) · Clinical Nutrition · doi:10.1016/j.clnu.2005.09.001 · Cited by 31
Malaguti, C., Nápolis, L. M., Villaça, D. S., Neder, J. A., Nery, L. E., & Corso, S. D. (2011) · The Journal of Strength and Conditioning Research · doi:10.1519/jsc.0b013e3181e501c1 · Cited by 30
Verhees, K. J. P., Pansters, N. A. M., Baarsma, H. A., Remels, A. H. V., Haegens, A., de Theije, C. C., Schols, A. M. W. J., Gosens, R., & LANGEN, R. C. J. (2013) · Respiratory Research · doi:10.1186/1465-9921-14-117 · Cited by 31
Self-citationSTEINER, M. C., Roubenoff, R., Tal‐Singer, R., & Polkey, M. I. (2012) · Thorax · doi:10.1136/thoraxjnl-2012-201765 · Cited by 30
Interaction between Physical Activity and Smoking on Lung, Muscle, and Bone in Mice
Cielen, N., Maes, K., Heulens, N., Troosters, T., Carmeliet, G., Janssens, W., & Gayan‐Ramirez, G. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2015-0181oc · Cited by 30
Schweitzer, L., Geisler, C., Johannsen, M., Glüer, C.-C., & Müller, M.-M. (2016) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2016.146 · Cited by 30
Ibrahim, W., Harvey‐Dunstan, T. C., & Greening, N. J. (2019) · Respirology · doi:10.1111/resp.13516 · Cited by 30
Sanchez, F. F., Faganello, M. M., Tanni, S. É., Lucheta, P. A., Pelegrino, N. G., Hasegawa, S., Ribeiro, S. M., & Godoy, I. (2011) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2011007500024 · Cited by 30
Role of nutrition in patients with coexisting chronic obstructive pulmonary disease and sarcopenia
Nan, Y., Zhou, Y., Dai, Z., Yan, T., Zhong, P., Zhang, F., Chen, Q., & Peng, L. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1214684 · Cited by 30
Τσεκούρα, Μ., Tsepis, E., Billis, E. V., & Gliatis, J. (2020) · Lung India · doi:10.4103/lungindia.lungindia_143_20 · Cited by 29
Attaway, A. H., Welch, N., Yadav, R., Bellar, A., Hatipoglu, U. S., Meli, Y. M., ENGELEN, M. P. K. J., Zein, J., & Dasarathy, S. (2021) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2021.1897560 · Cited by 29
Association of body mass index and COPD exacerbation among patients with chronic bronchitis
Shin, S. H., Kwon, S. O., Kim, V., Silverman, E. K., Kim, T., Kim, D. K., Hwang, Y. I., Yoo, K. H., Kim, W. J., & Park, H. Y. (2022) · Respiratory Research · doi:10.1186/s12931-022-01957-3 · Cited by 29
Hsu, M.-F., Ho, S., Kuo, H.-P., Wang, J., & Tsai, A. C. (2014) · PubMed · doi:10.3109/15412555.2013.863274 · Cited by 29
Dudgeon, D. J., & Baracos, V. E. (2016) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000222 · Cited by 29
Synergistic stimulation of myogenesis by glucocorticoid and IGF-I signaling
Pansters, N., LANGEN, R. C. J., Wouters, E. F. �., & Schols, A. M. W. J. (2012) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00503.2012 · Cited by 29
Self-citationFactores pronósticos en la EPOC
Soler‐Cataluña, J. J., & Martínez‐García, M. Á. (2007) · Archivos de Bronconeumología · doi:10.1157/13112967 · Cited by 29
Food Pyramid for Subjects with Chronic Obstructive Pulmonary Diseases
Rondanelli, M., Faliva, M. A., Peroni, G., Infantino, V., Gasparri, C., Iannello, G., Perna, S., Alalwan, T. A., Al-Thawadi, S. M., & Corsico, A. G. (2020) · International Journal of COPD · doi:10.2147/copd.s240561 · Cited by 28
Sen, P., Majumdar, U., Zein, J., Hatipoglu, U. S., & Attaway, A. H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252576 · Cited by 28
Furulund, E., Bemanian, M., Berggren, N., Madebo, T., Rivedal, S. H., Lid, T. G., & Fadnes, L. T. (2021) · International Journal of COPD · doi:10.2147/copd.s323736 · Cited by 28
Measurement of body composition as a surrogate evaluation of energy balance in obese patients
Rotella, C. M., & Dicembrini, I. (2015) · World Journal of Methodology · doi:10.5662/wjm.v5.i1.1 · Cited by 28
Yılmaz, D., Çapan, N., Canbakan, S., & Besler, H. T. (2015) · Nutrition Journal · doi:10.1186/s12937-015-0020-5 · Cited by 28
Overweight Is an Independent Risk Factor for Reduced Lung Volumes in Myotonic Dystrophy Type 1
Seijger, C., Drost, G., Posma, J. M., van Engelen, B. G. M., & Heijdra, Y. F. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152344 · Cited by 28
Dubé, B., & Laveneziana, P. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.02.20 · Cited by 28
Chua, J. R., Albay, A. B., & Tee, M. L. (2019) · International Journal of COPD · doi:10.2147/copd.s222809 · Cited by 28
Güell, M. R., Lobato, S. D., Trigo, G. R., Vélez, F. M., Miguel-Pagola, M. S., Cejudo, P., Ruiz, F. Ó., Muñoz, A., Iturri, J. B. G., García, A. G., et al. (2014) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2014.06.011 · Cited by 28
Differential Impact of Low Fat-Free Mass in People With COPD Based on BMI Classifications
Machado, F. V. C., Vogelmeier, C. F., Jörres, R. A., Watz, H., Bals, R., Welte, T., Spruit, M. A., Alter, P. J., & Franssen, F. M. E. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.11.040 · Cited by 27
Obesity and extent of emphysema depicted at CT
Gu, S., Li, R., Leader, J. K., Zheng, B., Bon, J. M., Gur, D., Sciurba, F. C., Jin, C., & Pu, J. (2015) · Clinical Radiology · doi:10.1016/j.crad.2015.01.007 · Cited by 27
Update on the Mechanisms of Muscle Dysfunction in COPD
Gea, J., & Barreiro, E. (2008) · Archivos de Bronconeumología · doi:10.1016/s1579-2129(08)60054-3 · Cited by 28
Ingadóttir, Á. R., Beck, A. M., Baldwin, C., Weekes, C. E., Geirsdóttir, Ó. G., Ramel, A., Gíslason, Þ., & Gunnarsdóttir, I. (2018) · British Journal Of Nutrition · doi:10.1017/s0007114517003919 · Cited by 27
Reversibility of cachexia after bilateral lung transplantation
Habedank, D., Ewert, R., Hetzer, R., & Anker, S. D. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.11.077 · Cited by 27
van Venrooij, L. M. W., van Leeuwen, P. A. M., de Vos, R., Borgmeijer-Hoelen, M. M. M. J., & de Mol, B. A. J. M. (2009) · Clinical Nutrition · doi:10.1016/j.clnu.2009.01.016 · Cited by 27
Nutritional status in patients with chronic pancreatitis
Verhaegh, B. P. M., Reijven, P. L. M., Prins, M. H., Brouns, J., Masclee, A., & Keulemans, Y. C. A. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.199 · Cited by 26
Nutritional status, gender and marital status in patients with chronic obstructive pulmonary disease
Odencrants, S., Bjuström, T., Wiklund, N., & Blomberg, K. (2013) · Journal of Clinical Nursing · doi:10.1111/jocn.12222 · Cited by 26
Skinfold Anthropometry –The Accurate Method for Fat Free Mass Measurement in COPD
Hronek, M., Kovařík, M., Aimova, P. P., Koblížek, V., Pavlíková, L., Salajka, F., & Zadák, Z. (2013) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2013.781151 · Cited by 26
de van der Schueren, M. A. E., de Smoker, M., Leistra, E., & Kruizenga, H. M. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.08.024 · Cited by 26
van der Heyden, B., van de Worp, W. R. P. H., van Helvoort, A., Theys, J., Schols, A. M. W. J., LANGEN, R. C. J., & Verhaegen, F. (2019) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00465.2019 · Cited by 27
Self-citationLan, C., Su, C., Chou, L.-L., Yang, M., Lim, C., & Wu, Y. (2012) · Heart & Lung · doi:10.1016/j.hrtlng.2012.02.010 · Cited by 26
Hitzl, A. P., Jörres, R. A., Heinemann, F., Pfeifer, M., & Budweiser, S. (2009) · Clinical Nutrition · doi:10.1016/j.clnu.2009.08.002 · Cited by 26
Marinari, S., Manigrasso, M. R., & Benedetto, F. D. (2013) · Multidisciplinary Respiratory Medicine · doi:10.1186/2049-6958-8-40 · Cited by 26
Demircioğlu, H., Cihan, F. G., Kutlu, R., Yosunkaya, Ş., & Zamanı, A. (2020) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1909-36 · Cited by 25
Pathophysiology of cachexia and characteristics of dysphagia in chronic diseases
Matsuo, H., & Sakuma, K. (2022) · Asia-Pacific Journal of Oncology Nursing · doi:10.1016/j.apjon.2022.100120 · Cited by 25
Diago, C. A. A., Martín-Audera, P., Calvo, J. A., Lavín, B. A., Guerra-Ruiz, A. R., Boucle, D., Pargada, D. J. F., Berja, A., Martín, F., Casanova, C., et al. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1100211 · Cited by 25
Zuur-Telgen, M. C., Brusse-Keizer, M. G. J., VanderValk, P. D. L. P. M., van der Palen, J. A. M., Kerstjens, H. A. M., & Hendrix, M. G. R. (2013) · CHEST Journal · doi:10.1378/chest.13-1063 · Cited by 25
Current best practice in pulmonary rehabilitation for chronic obstructive pulmonary disease
Blasio, F. D., & Polverino, M. (2012) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465812444712 · Cited by 26
Role of accelerated aging in limb muscle wasting of patients with COPD
Lakhdar, R., McGuinness, D., Drost, E., Shiels, P. G., Bastos, R., MacNee, W., & Rabinovich, R. (2018) · International Journal of COPD · doi:10.2147/copd.s155952 · Cited by 25
van Isselt, E. F. V. D., van Eijk, M., van Geloven, N., Groenewegen-Sipkema, K. H., van den Berg, J. W., Nieuwenhuys, C. M. A., Chavannes, N. H., & Achterberg, W. P. (2019) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2019.02.025 · Cited by 25
Miki, K., Maekura, R., Nagaya, N., Kitada, S., Miki, M., Yoshimura, K., Tateishi, Y., Motone, M., Hiraga, T., Mori, M., et al. (2013) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-13-37 · Cited by 24
Rinaldi, S., Gilliland, J., O’Connor, C. P., Seabrook, J. A., Mura, M., & Madill, J. (2021) · Respiration · doi:10.1159/000512732 · Cited by 24
Psoas Muscle Density Evaluated by Chest CT and Long-Term Mortality in COPD Patients
Ezponda, A., Casanova, C., Cabrera, C., Martín-Palmero, Á., Marín‐Oto, M., Marín, J. M., Pinto-Plata, V., Divo, M. J., Celli, B. R., Zulueta, J. J., et al. (2021) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2021.04.012 · Cited by 24
The 2014 ESPEN Arvid Wretlind Lecture: Metabolism & nutrition: Shifting paradigms in COPD management
Schols, A. M. W. J. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2015.09.005 · Cited by 24
Self-citationShin, S., Park, H. Y., Kim, H., Kim, H. K., Choi, Y. S., Kim, J., Um, S., Chung, M. J., Kim, H., Kwon, O. J., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.01148-2016 · Cited by 24
Obesity and chronic obstructive pulmonary disease: recent knowledge and future directions
Hanson, C., & LeVan, T. D. (2016) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000354 · Cited by 24
Nishiki, K., Nojiri, M., Kato, R., Shinomiya, S., Oikawa, T., Ishizaki, T., Toga, H., & Mizuno, S. (2021) · International Journal of COPD · doi:10.2147/copd.s339243 · Cited by 25
Verhees, K. J. P., Pansters, N. A. M., Schols, A. M. W. J., & LANGEN, R. C. J. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319180011 · Cited by 24
Self-citationMaters, G. A., de Voogd, J. N., Sanderman, R., & Wempe, J. B. (2014) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2014.898026 · Cited by 24
Crawford, G. B., Robinson, J. A., Hunt, R. W., Piller, N., & Esterman, A. (2009) · Journal of Palliative Medicine · doi:10.1089/jpm.2009.0093 · Cited by 24
Immunologic Impact of Nutrient Depletion in Chronic Obstructive Pulmonary Disease
Herzog, R., & Cunningham-Rundles, S. (2011) · Current Drug Targets · doi:10.2174/138945011794751500 · Cited by 23
“FFM index (FFMI) is a significant predictor of survival in COPD, independent of BMI [15-18].”
BackgroundThe impact of waiting list BMI changes on the short-term outcomes of lung transplantation
Jomphe, V., Mailhot, G., Damphousse, V., Tahir, M.-R., Receveur, O., Poirier, C., & Ferraro, P. (2018) · Transplantation · doi:10.1097/tp.0000000000001919 · Cited by 23
“8) Age at transplant: median (IQR), y 30 (23-49) 52 (38-59) 55 (51-61) Underlying diseases, n (%)”
Qiao, X., Hou, G., Kang, J., Wang, Q., & Yin, Y. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.833796 · Cited by 23
Body mass index is associated with clinical outcomes in idiopathic pulmonary fibrosis
Yoon, H., Kim, H., Bae, Y., & Song, J. W. (2024) · Scientific Reports · doi:10.1038/s41598-024-62572-4 · Cited by 23
Body Composition in Severe Refractory Asthma: Comparison with COPD Patients and Healthy Smokers
Minas, M., Papaioannou, A. Ι., Tsaroucha, A., Daniil, Z. D., Hatzoglou, C., Sgantzos, M. N., Gourgoulianis, K. I., & Κostikas, Κ. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013233 · Cited by 23
Tunsupon, P., & Mador, M. J. (2017) · Lung · doi:10.1007/s00408-017-0053-y · Cited by 23
Kneppers, A. E. M., Haast, R. A. M., LANGEN, R. C. J., Verdijk, L. B., Leermakers, P. A., Gosker, H. R., van Loon, L. J. C., Lainščak, M., & Schols, A. M. W. J. (2019) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12370 · Cited by 23
Self-citationChildhood allergies, birth order and family size
Cullinan, P. (2005) · Thorax · doi:10.1136/thx.2004.039701 · Cited by 23
Brauwers, B., Machado, F. V. C., Beijers, R. J. H. C. G., Spruit, M. A., & Franssen, F. M. E. (2023) · Nutrients · doi:10.3390/nu15245136 · Cited by 22
Korkmaz, C., Demirbaş, S., Vatansev, H., Yıldırım, E., Teke, T., & Zamanı, A. (2020) · Journal of International Medical Research · doi:10.1177/0300060520919567 · Cited by 22
Cachexia: prevalence and impact in medicine
Tan, B. H. L., & Fearon, K. C. H. (2008) · Current Opinion in Internal Medicine · doi:10.1097/mci.0b013e328315510b · Cited by 22
Johari, S. M., & Shahar, S. (2014) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2014.04.003 · Cited by 22
Levinson, B., & Gertner, J. M. (2012) · e-SPEN Journal · doi:10.1016/j.clnme.2012.07.004 · Cited by 22
Slinde (2010) · International Journal of COPD · doi:10.2147/copd.s12544 · Cited by 22
Whole-body resting and exercise-induced lipolysis in sarcopaenic patients with COPD
Franssen, F. M. E., Sauerwein, H. P., Rutten, E. P. A., Wouters, E. F. �., & Schols, A. M. W. J. (2008) · European Respiratory Journal · doi:10.1183/09031936.00014008 · Cited by 22
Self-citationMaltais, F. (2013) · The Physician and Sportsmedicine · doi:10.3810/psm.2013.02.2001 · Cited by 22
Metadata
- Authors
- Schols, A. M., Broekhuizen, R., Weling-Scheepers, C. A., & Wouters, E. F.
- Affiliations
- Maastricht University (NL)
- Corresponding author
- Schols, Annemie MWJ
- Venue
- The American Journal of Clinical Nutrition
- Publisher
- Elsevier BV
- Published
- 2005-07
- Volume
- 82
- Issue
- 1
- Pages
- 53-59
- ISSN
- 0002-9165 (ISSN-L)
- OpenAlex
- W2150051820
- Cited by
- 902
- References
- 35
- Citations by year
- 2026: 24 · 2025: 32 · 2024: 34 · 2023: 44 · 2022: 41 · 2021: 47 · 2020: 49 · 2019: 49 · 2018: 45 · 2017: 45 · 2016: 60 · 2015: 57 · 2014: 61 · 2013: 55 · 2012: 37
- FWCI
- 19.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 6456 d)
- Locations
- American Journal of Clinical Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Keywords
- chronic obstructive pulmonary disease, body composition, mortality, fat-free mass index, fat mass index, skeletal muscle index, cachexia, muscle atrophy, semistarvation, disease severity
- MeSH terms
- Body Composition, Body Weight, Cachexia, Female, Humans, Male, Middle Aged, Reference Values, Respiratory Function Tests, Severity of Illness Index, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.